Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Late-Stage Pipeline

26%

7 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

14 recruiting

Enrollment Performance

Analytics

N/A
5(26.3%)
Phase 4
5(26.3%)
Phase 1
3(15.8%)
Phase 2
3(15.8%)
Phase 3
2(10.5%)
Early Phase 1
1(5.3%)
19Total
N/A(5)
Phase 4(5)
Phase 1(3)
Phase 2(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials
NCT07576543Phase 4Not Yet Recruiting

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Role: collaborator

NCT07576517Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

Role: collaborator

NCT06538883Not ApplicableRecruiting

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT07530432Not Yet Recruiting

Analysis of Influencing Factors for the Development of PTSD in Emergency Department Trauma Patients

Role: lead

NCT06099912Recruiting

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

Role: collaborator

NCT07266181Phase 1Recruiting

Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy

Role: lead

NCT07240987Phase 1Not Yet Recruiting

Mesenchymal Stem Cells for Chronic Kidney Diseases

Role: lead

NCT07288749Phase 3Not Yet Recruiting

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Role: collaborator

NCT07267117Recruiting

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

Role: collaborator

NCT06716658Phase 2Recruiting

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Role: collaborator

NCT04244981Phase 4Recruiting

Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery

Role: collaborator

NCT07198659Early Phase 1Recruiting

A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer

Role: lead

NCT06482749Not ApplicableRecruiting

Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Role: collaborator

NCT06743867Phase 1Recruiting

The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma

Role: collaborator

NCT01793831Not ApplicableRecruiting

Standardized Fecal Microbiota Transplantation for Crohn's Diseases

Role: collaborator

NCT06029036Phase 2Recruiting

A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer

Role: collaborator

NCT05600634Recruiting

Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation

Role: collaborator

NCT03651986Unknown

Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules

Role: collaborator

NCT05816642Not ApplicableUnknown

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Role: collaborator

NCT05668910Unknown

Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA

Role: collaborator